or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    VINC F Vincera Pharma, Inc. -7.11
    STTK F Shattuck Labs, Inc. -9.01
    PRLD F Prelude Therapeutics Incorporated 0.57
    ENLV F Enlivex Therapeutics Ltd. -13.83
    AFMD F Affimed Therapeutics B.V. -2.94
    RLAY F Relay Therapeutics, Inc. -0.43
    TCRX F TScan Therapeutics, Inc. -4.37
    SNDX F Syndax Pharmaceuticals, Inc. -2.19
    GMAB F Genmab A/S 0.10
    TCBP F TC BioPharm (Holdings) plc -0.03
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Cancer Lymphoma Medicine Biopharmaceutical Clinical Medicine Biotechnology Immune System Immunology Life Sciences Treatment Of Cancer Acute Myeloid Leukemia Advanced Solid Tumors Blastoma Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Hematologic Malignancies Immunotherapies Immunotherapy Lymphocytic Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 5.11
    CANC D Tema Oncology ETF 5.02
    MNTL D Tema Neuroscience and Mental Health ETF 4.48
    GNOM F Global X Genomics & Biotechnology ETF 4.31
    IBRN C iShares Neuroscience and Healthcare ETF 3.9
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CANC to GNOM Compare CANC to MNTL Compare MNTL to GNOM

        Solid Tumors Stocks Recent News

        Date Stock Title
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 20 RLAY Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround
        Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
        Nov 19 RLAY Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround
        Nov 18 SNDX Syndax secures FDA OK for new kind of leukemia drug
        Nov 18 SNDX FDA approves Syndax’s Revuforj to treat leukaemia
        Nov 16 STTK Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 SNDX Syndax wins FDA approval for leukemia drug revumenib
        Nov 15 SNDX Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
        Nov 15 GMAB Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 STTK Shattuck Labs sees cash runway into 2027
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Cancer Biopharmaceutical Cancer Immunotherapy Cell Therapy Biotechnology Immune System Lymphoma Medicine Tumor Acute Myeloid Leukemia Apoptosis Autoimmune Disease Cancer Treatment Cell Biology Clinical Medicine Immunotherapy Non Small Cell Lung Cancer Ovarian Cancer Treatment Of Cancer Virotherapy
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags